Led by increased adoption of its Impella heart pumps, Abiomed reported a 40 percent growth in sales to $103 million during the first quarter of fiscal year 2017. The company’s GAAP earnings also rose from $0.20 per diluted share to $0.29 per diluted share.

During the second quarter of 2016, Boston Scientific reported sales of $2.13 billion, a 15 percent increase compared with the same period last year.

The American College of Cardiology (ACC) and American Heart Association (AHA) released statements this week after the federal government revealed proposals on bundled payments for cardiac care.

Bristol-Myers Squibb agreed to pay $30 million to the California Department of Insurance to settle allegations the company engaged in marketing fraud and paid kickbacks to physicians.

After several months of buildup, the CMS Hospital Compare website began to offer overall hospital star ratings July 27. According to the agency, the system is meant to offer patients a way to quickly and uniformly compare potential hospitals.

Edwards Lifesciences raised its full-year sales and adjusted earnings per share guidance for 2016 after posting increases in sales and earnings during the quarter that ended on June 30.

Led by strong sales growth in its atrial fibrillation and heart failure divisions, St. Jude Medical’s second quarter sales increased 11 percent to $1.56 billion compared with the same period last year. The quarter ended July 2.

The Centers for Medicare & Medicaid Services (CMS) announced on July 25 a five-year proposed bundled payments model for hospitals that treat Medicare patients following an MI or bypass surgery. CMS also announced a proposed five-year cardiac rehabilitation incentive payment model to encourage hospitals to refer patients to cardiac rehabilitation.